On May 27, 2020, Thermo Fisher Scientific and CSL entered into a strategic long term partnership. Thermo Fisher Scientific will support CSL's product portfolio by leveraging its pharma services network, including drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics. Through a long-term lease agreement with CSL, Thermo Fisher Scientific will operate a new state-of-the-art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in mid-2021.
Homburger advised Thermo Fisher Scientific in all legal matters on its partnership with CSL. The Homburger team included Daniel Daeniker (Corporate | M&A), Luca Dal Molin (IP | IT), Andrea Grimm (Real Estate), Mirko Stiefel (Corporate | M&A) and Andrea Zocchi (IP | IT).